SignalPoint Asset Management LLC Has $504,000 Stock Holdings in Clover Health Investments, Corp. (NASDAQ:CLOV)

SignalPoint Asset Management LLC raised its holdings in Clover Health Investments, Corp. (NASDAQ:CLOV) by 6.2% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 160,074 shares of the company’s stock after acquiring an additional 9,390 shares during the quarter. SignalPoint Asset Management LLC’s holdings in Clover Health Investments were worth $504,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Graypoint LLC acquired a new position in Clover Health Investments in the 4th quarter valued at approximately $632,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new stake in shares of Clover Health Investments in the 3rd quarter valued at $1,228,000. Connor Clark & Lunn Investment Management Ltd. grew its holdings in Clover Health Investments by 75.7% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,128,171 shares of the company’s stock worth $3,181,000 after purchasing an additional 485,987 shares during the period. State Street Corp grew its holdings in shares of Clover Health Investments by 65.0% during the third quarter. State Street Corp now owns 2,189,380 shares of the company’s stock valued at $6,174,000 after buying an additional 862,621 shares during the last quarter. Finally, Janus Henderson Group PLC acquired a new position in shares of Clover Health Investments during the third quarter valued at about $477,000. 19.77% of the stock is currently owned by institutional investors and hedge funds.

Clover Health Investments Stock Up 6.4 %

Shares of CLOV stock opened at $3.98 on Thursday. Clover Health Investments, Corp. has a 52 week low of $0.61 and a 52 week high of $4.71. The firm’s 50-day simple moving average is $3.34 and its two-hundred day simple moving average is $2.96.

Clover Health Investments (NASDAQ:CLOV) last announced its quarterly earnings data on Wednesday, November 6th. The company reported ($0.02) EPS for the quarter, topping the consensus estimate of ($0.03) by $0.01. The business had revenue of $330.99 million for the quarter, compared to analyst estimates of $347.60 million. Clover Health Investments had a negative net margin of 5.92% and a negative return on equity of 25.46%. During the same quarter in the previous year, the firm posted ($0.09) earnings per share. Research analysts expect that Clover Health Investments, Corp. will post -0.12 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the stock. UBS Group assumed coverage on shares of Clover Health Investments in a report on Monday, October 7th. They set a “neutral” rating and a $4.00 price target on the stock. Craig Hallum started coverage on shares of Clover Health Investments in a research report on Tuesday, December 17th. They issued a “buy” rating and a $6.00 price objective on the stock.

About Clover Health Investments

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.